The Biopharmaceutical Analytical Testing Services Market is being driven by Increase in demand for mAbs
The Biopharmaceutical Analytical Testing Services Market is expected to grow at a CAGR of 15.2% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 5481.3 million. The global research and development expenditure is experiencing consistent growth, with developing countries exhibiting faster economic expansion. This trend is projected to result in an increased number of laboratories and research facilities being established during the forecast period. In the pharmaceutical sector, the rise in research facilities will lead to heightened demand for biopharmaceutical analytical testing services. Innovation and knowledge expansion remain priorities for countries, ensuring that research and development spending will persist throughout the forecast period. This sustained investment will fuel the growth of sectors such as drug discovery and pharmaceutical research, which heavily rely on analytical testing services to produce safe and effective biopharmaceutical products.
Get more information on Biopharmaceutical Analytical Testing Services Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
224 |
|
Base year |
2024 |
|
Historic period |
2019-2023 |
|
Forecast period |
2025-2029 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 15.2% |
|
Market growth 2025-2029 |
USD 5481.3 million |
|
Market structure |
market_structure.ucfirst |
|
YoY growth 2024-2025(%) |
12.9 |
|
Key countries |
US, China, Japan, UK, Germany, France, Canada, India, South Korea, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Biopharmaceutical Analytical Testing Services Market encompasses the analysis of proteins and compounds in the context of drug discovery and development. This includes drug release testing for biotherapeutics, identifying impurities in biopharmaceutical R&D, and analyzing drugs, metabolites, and pharmaceutical components in biological fluids such as blood, plasma, serum, urine, saliva, tissue extracts, and other mixtures. The ultimate goal is to ensure the safety, efficacy, and quality of biologics and therapeutics for the patient's health, while adhering to fund systems regulations.
The Biopharmaceutical Analytical Testing Services Market is a significant segment of the global Life Sciences Services industry. This market encompasses the testing of proteins, compounds, and drug candidates for various applications, including drug discovery, drug release testing, and quality control of biotherapeutics. Factors driving market growth include the increasing therapeutic potential of biopharmaceuticals, particularly in areas such as immunotherapy and immune responses. The market caters to biopharmaceutical R&D, focusing on drug purity, impurities, and characterization to ensure safety and efficacy. As the life sciences sector continues to evolve, the demand for contract research organizations and contract manufacturing organizations offering specialized analytical testing services will increase. This growth is fueled by the expanding pipeline of novel drug targets and the need for rigorous regulatory compliance.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
